Furthermore, differences in the number of detectable human breast cancer cells in CD44-enriched versus CD44-depleted chimeras indicates that our detection of human cells by keratin expression is human-specific, with no cross-reactivity to mouse. This evidence concerns the gene CD44 and breast cancer.